Literature DB >> 1082894

Regualtion of the immune response to tumor antigens. I. Immunosuppressor cells in tumor-bearing hosts.

S Fujimoto, M I Greene, A H Sehon.   

Abstract

A/Jax mice were rendered immune to the syngeneic and transplantable methylcholanthrene-induced Sarcoma 1509a by the surgical removal of the tumor 7 days after implantation; subsequent injection i.v. transfer of 10(7) to 10(8) washed thymus or spleen cells of tumor-bearing animals (TBA) to immune animals significantly inhibited the rejection of the tumor; this suppressive effect was entirely abolished by the treatment of these lymphocytes with anti-theta serum or anti-thymocyte serum (ATS) and complement before adoptive transfer. On the other hand, an equal number of thymus or spleen cells of normal animals or of animals bearing an unrelated tumor had no suppressive effect. Treatment of normal syngeneic animals with ATS after tumor cell inoculation or splenectomy of TBA resulted in the suppression of the tumor growth. The serum of TBA had no effect on tumor growth in immune syngeneic mice. Together these results suggest that TBA possess immunosuppressor T cells regulating negatively their immune response to the tumor.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1082894

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  77 in total

1.  Two-color flow cytometric analysis of splenic lymphocyte subpopulations in patients with gastric cancer.

Authors:  M Takahashi; S Fujimoto; M Takai; K Ohno; F Endoh; Y Masuda; Y Masuda; G Obata
Journal:  Surg Today       Date:  1992       Impact factor: 2.549

Review 2.  Regulatory mechanisms of antitumor T cell responses in the tumor-bearing state.

Authors:  H Fujiwara; T Hamaoka
Journal:  Immunol Res       Date:  1995       Impact factor: 2.829

Review 3.  Immunosuppression in human tumor-host interaction: role of cytokines and alterations in signal-transducing molecules.

Authors:  R Kiessling; K Kono; M Petersson; K Wasserman
Journal:  Springer Semin Immunopathol       Date:  1996

4.  Reversal of defective lymphoproliferation in postoperative patients with colon cancer.

Authors:  L Schindler; M Leroux; G F Zimmermann; M Betzler; H Kirchner
Journal:  J Cancer Res Clin Oncol       Date:  1987       Impact factor: 4.553

5.  Radiation-induced augmentation of the response of A/J mice to SaI tumor cells.

Authors:  R E Anderson; S Tokuda; W L Williams; N L Warner
Journal:  Am J Pathol       Date:  1982-07       Impact factor: 4.307

6.  Adjuvants in the induction of suppressor cells.

Authors:  R Neta; S B Salvin
Journal:  Infect Immun       Date:  1979-02       Impact factor: 3.441

7.  Regulation of the immune response to tumor antigen.

Authors:  M I Greene; L L Perry; B Benacerraf
Journal:  Am J Pathol       Date:  1979-04       Impact factor: 4.307

8.  Regulation of immune responses against the syngeneic ADJ-PC-5 plasmacytoma in BALB/c mice. II. Suppression of T-cell cytotoxicity by pretreatment of mice with subimmunogenic doses of tumour cells.

Authors:  J Cihak; H W Ziegler; E Kölsch
Journal:  Immunology       Date:  1981-05       Impact factor: 7.397

9.  Augmentation of the anti-tumor therapeutic efficacy of long-term cultured T lymphocytes by in vivo administration of purified interleukin 2.

Authors:  M A Cheever; P D Greenberg; A Fefer; S Gillis
Journal:  J Exp Med       Date:  1982-04-01       Impact factor: 14.307

10.  In vitro generation of cytotoxic lymphocytes against radiation- and radiation leukemia virus-induced tumors. III. Suppression of anti-tumor immunity in vitro by lymphocytes of mice undergoing radiation leukemia virus-induced leukemogenesis.

Authors:  E Yefenof; A Meidav; E Kedar
Journal:  J Exp Med       Date:  1980-12-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.